Ramsay David A

Ramsay David A serves as the Executive Vice President at Halozyme Therapeutics, Inc., a company focused on innovative therapies for serious diseases. His trading activity includes both sales and purchases, with a significant focus on Halozyme Therapeutics (HALO) and Savara Inc. (SVRA). Between November 18, 2024, and July 2, 2026, Ramsay reported 10 disclosures, with transactions valued between $3.1 million and $121.2K, including a notable grant/exercise worth over $3 million on July 2, 2026.